Clinical Trial Update: Treatment of Frostbite Sequelae With Botulinum Toxin A [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating botulinum toxin A for frostbite sequelae has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cold Hypersensitivity
• Frostbite
• Hand-arm Vibration Syndrome
• Neuropathic Pain
• Vascular Injuries

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: University Hospital of North Norway | Conditions: Cold Hypersensitivity, Vascular System Injuries | Phase 2 | Status: WITHDRAWN